Family · Pharmaceutical analytical standards
Olanzapine
An atypical antipsychotic of the thienobenzodiazepine family, patented in 1991. Approved in the United States in 1996 for psychotic disorders, it is mainly used for schizophrenia and bipolar disorder. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It was born from the search for a 'cousin' of clozapine that would not need regular blood monitoring: chemists replaced one of its benzene rings with a thiophene ring.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
